These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21949038)

  • 1. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease.
    Qari MH; Dier U; Mousa SA
    Clin Appl Thromb Hemost; 2012; 18(2):195-200. PubMed ID: 21949038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profile of sickle cell disease in Oman.
    Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
    Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
    Nur E; van Beers EJ; Martina S; Cuccovillo I; Otten HM; Schnog JJ; Meijers JC; Mantovani A; Brandjes DP; Bottazzi B; Biemond BJ;
    Blood Cells Mol Dis; 2011 Mar; 46(3):189-94. PubMed ID: 21256776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
    Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
    Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
    Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
    Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI; O'Gorman MR; Brown DL
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.
    Ataga KI; Moore CG; Hillery CA; Jones S; Whinna HC; Strayhorn D; Sohier C; Hinderliter A; Parise LV; Orringer EP
    Haematologica; 2008 Jan; 93(1):20-6. PubMed ID: 18166781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Perioperative immunologic changes in colorectal cancer patients].
    Neagu S; Lerescu L; Costea R; Tucureanu C; Caraş I; Gangură G; Pitica R; Sălăgeanu A
    Chirurgia (Bucur); 2012; 107(1):59-65. PubMed ID: 22480118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA; Adly AA; Ismail EA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease.
    Francis RB; Haywood LJ
    J Natl Med Assoc; 1992 Jul; 84(7):611-5. PubMed ID: 1629925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome.
    Suharti C; van Gorp EC; Setiati TE; Dolmans WM; Djokomoeljanto RJ; Hack CE; ten CH; van der Meer JW
    Thromb Haemost; 2002 Jan; 87(1):42-6. PubMed ID: 11858187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion.
    Mousa SA; Al Momen A; Al Sayegh F; Al Jaouni S; Nasrullah Z; Al Saeed H; Alabdullatif A; Al Sayegh M; Al Zahrani H; Hegazi M; Al Mohamadi A; Alsulaiman A; Omer A; Al Kindi S; Tarawa A; Al Othman F; Qari M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):365-76. PubMed ID: 20530056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host and environmental factors influencing respiratory secretion of pro-wheezing biomarkers in preterm children.
    Matías V; San Feliciano L; Fernández JE; Lapeña S; Garrido E; Ardura J; Soga MJ; Aragón MP; Remesal A; Benito F; Andrés J; Centeno F; Marugán V; Bachiller R; Bermejo-Martin JF
    Pediatr Allergy Immunol; 2012 Aug; 23(5):441-7. PubMed ID: 22554061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients.
    Bao B; Prasad AS; Beck FW; Snell D; Suneja A; Sarkar FH; Doshi N; Fitzgerald JT; Swerdlow P
    Transl Res; 2008 Aug; 152(2):67-80. PubMed ID: 18674741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis.
    Francis RB
    Haemostasis; 1989; 19(2):105-11. PubMed ID: 2731776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
    Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
    Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.